Colgate-Palmolive (NYSE:CL) Insider Sells $1,506,320.53 in Stock

Colgate-Palmolive Company (NYSE:CL) insider Sally Massey sold 15,851 shares of the business’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the transaction, the insider directly owned 13,751 shares in the company, valued at $1,306,757.53. This trade represents a 53.55% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Colgate-Palmolive Stock Down 0.2%

CL traded down $0.23 during trading on Monday, reaching $94.18. 5,368,344 shares of the stock were exchanged, compared to its average volume of 7,733,365. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42. The stock’s 50 day moving average price is $82.13 and its two-hundred day moving average price is $81.55. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $100.18. The stock has a market cap of $75.92 billion, a P/E ratio of 35.95, a price-to-earnings-growth ratio of 4.26 and a beta of 0.29.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. During the same quarter last year, the firm posted $0.91 EPS. The company’s quarterly revenue was up 5.8% on a year-over-year basis. Equities analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be issued a dividend of $0.52 per share. The ex-dividend date of this dividend is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. Colgate-Palmolive’s payout ratio is presently 79.39%.

Institutional Investors Weigh In On Colgate-Palmolive

Several institutional investors and hedge funds have recently bought and sold shares of the company. Smithfield Trust Co raised its position in shares of Colgate-Palmolive by 37.2% in the 4th quarter. Smithfield Trust Co now owns 12,474 shares of the company’s stock valued at $987,000 after buying an additional 3,385 shares in the last quarter. Bleakley Financial Group LLC increased its stake in Colgate-Palmolive by 86.9% in the fourth quarter. Bleakley Financial Group LLC now owns 39,162 shares of the company’s stock valued at $3,095,000 after acquiring an additional 18,207 shares during the last quarter. CBIZ Investment Advisory Services LLC raised its position in Colgate-Palmolive by 86.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock valued at $26,000 after purchasing an additional 150 shares in the last quarter. Harbour Investments Inc. lifted its stake in Colgate-Palmolive by 206.4% during the fourth quarter. Harbour Investments Inc. now owns 23,115 shares of the company’s stock worth $1,827,000 after purchasing an additional 15,570 shares during the last quarter. Finally, Allstate Corp boosted its holdings in shares of Colgate-Palmolive by 104.1% in the 4th quarter. Allstate Corp now owns 57,058 shares of the company’s stock valued at $4,509,000 after purchasing an additional 29,108 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a research report on Monday, February 2nd. Citigroup upped their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. Bank of America raised their price objective on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Deutsche Bank Aktiengesellschaft increased their target price on Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Finally, The Goldman Sachs Group restated a “buy” rating and issued a $94.00 price target on shares of Colgate-Palmolive in a research note on Saturday, January 31st. Eleven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $94.47.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.